
|Articles|July 1, 2004
Pegaptanib sodium found to be effective for exudative AMD
Rates of stable or improved vision were 33% in the pegaptanib sodium group compared with 23% for controls.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























